SK bioscience

본문바로가기

사이트맵 닫기

PR

SK bioscience company news updates

Press releases

SK bioscience Presents Next Pandemic Countermeasures for Pandemic Accord

2023.07.13
SK bioscience-Government Pharmaceutical Organization Sign Memorandum of Understanding to Strengthen Vaccine Infrastructure in Thailand

2023. 07. 05
SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate

2023.06.30
SK bioscience and the Peter Doherty Institute for Infection and Immunity Join Forces Against Influenza

2023.06.27
SK bioscience COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization

2023.06.19
SK bioscience Receives Marketing Authorization of COVID-19 Vaccine from UK MHRA

2023.05.30
SK bioscience Presents Solution for Equitable Access of Vaccine at The Regionalized Vaccine Manufacturing Collaborative

2023.05.23
SK bioscience Announces Contract Manufacturing Agreement with MSD for Next-Generation Zaire Ebola Vaccine Candidate

2023.05.08
SK bioscience-International Vaccine Institute Announce Co-Winners of Second Park MahnHoon Award

2023.03.07
SK bioscience’s Herpes Zoster Vaccine Secures the Highest Market Share in South Korea

2023. 02. 28